Timing of Melanoma Immunotherapy Could Be Key to Outcomes: Study
MONDAY, March 6, 2023 -- A tweak in timing may make an immune-system therapy much more effective for patients undergoing surgery for advanced melanoma, a new clinical trial has found.
Researchers showed that giving the therapy — a drug called... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 6, 2023 Category: General Medicine Source Type: news
Society for Melanoma Research 2022: Adjuvant and TIL Therapy Society for Melanoma Research 2022: Adjuvant and TIL Therapy
Jeffrey S. Weber, MD, PhD, discusses abstracts presented at the recent Society for Melanoma Research meeting in Edinburgh, Scotland.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 4, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Pembro Before and After Melanoma Surgery Boosts Outcomes Pembro Before and After Melanoma Surgery Boosts Outcomes
Patients with advanced melanoma have better event-free survival if pembrolizumab is given both before and after surgery; the findings tally with the mechanism of action of the drug, say researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 2, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Vitamin B3 Doesn't Cut Skin Cancer Risk After Organ Transplant
(MedPage Today) -- Daily treatment with nicotinamide, an active water-soluble form of vitamin B3, failed to reduce the risk of non-melanoma skin cancer in solid-organ transplant recipients with a history of skin cancer, a phase III study in Australia... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 1, 2023 Category: Cardiology Source Type: news
Neoantigen Vaccine With Pembrolizumab Has Clear Benefit in Melanoma Neoantigen Vaccine With Pembrolizumab Has Clear Benefit in Melanoma
Jeffrey S. Weber, MD, PhD, discusses recently released data on a new antigen vaccine with pembrolizumab.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 1, 2023 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news
Manglik, Arkin, Bastian receive ASPIRE Award for moonshot cancer research
Funding from the Mark Foundation for Cancer Research will fuel high-risk, high-impact research on uveal melanoma. (Source: UCSF School of Pharmacy News)
Source: UCSF School of Pharmacy News - February 23, 2023 Category: Universities & Medical Training Source Type: news
Manglik, Arkin, Bastian receive Mark Foundation ASPIRE Award for moonshot cancer research
Funding from the Mark Foundation for Cancer Research will fuel high-risk, high-impact research on uveal melanoma. (Source: UCSF School of Pharmacy News)
Source: UCSF School of Pharmacy News - February 23, 2023 Category: Universities & Medical Training Source Type: news
Near-eradication of a debilitating parasitic disease is a pillar of Carter's legacy
In 2015, millions of people around the world tuned in to hear President Jimmy Carter announce that his cancer -- metastatic melanoma -- had spread to his brain, but he didn't focus solely on his own disease. Rather, he used the international attention to talk about an illness he did not have. (Source: CNN.com - Health)
Source: CNN.com - Health - February 22, 2023 Category: Consumer Health News Source Type: news
Pediatric Melanoma: Incidence, Risk Factors, and the ABCDE Rule Pediatric Melanoma: Incidence, Risk Factors, and the ABCDE Rule
Risk factors for melanoma in children are like those in adults, and include a family history of melanoma, large/giant congenital nevi, and the presence of many atypical appearing nevi.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 17, 2023 Category: Consumer Health News Tags: Dermatology News Source Type: news
Janssen Data at ASCO GU Support Ambition to Transform Treatment of Prostate and Bladder Cancer Through Precision Medicine and Early Intervention
RARITAN, N.J., February 13, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced plans to present more than 20 abstracts featuring seven oncology therapies from its robust portfolio and pipeline at the annual American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, taking place in San Francisco on February 16-18. Building on more than a decade of leadership in the development of medicines for people diagnosed with GU cancers, Janssen will present data demonstrating its ambition to advance patient-centered treatment through precision medicine, real-world evidence a...
Source: Johnson and Johnson - February 13, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Biotech's Drug Pipeline Expands From Melanoma To Other Cancers
is the IBD Stock of the Day as the biotech expands its drug pipeline. IMCR stock has forged a cup with handle with an entry point of 65.10. X On the stock market today, the biotechnology company rose 4.8% to 64.67. The company's primary product, Kimmtrak, is a treatment for a form of melanoma. In…#ibdstockofday #kimmtrak #immunocore #otherimmunocoredrugs #imcr #jpmorgan #jessicafye #biotechstockapioneer #tcr #justinzelin (Source: Reuters: Health)
Source: Reuters: Health - February 13, 2023 Category: Consumer Health News Source Type: news
Africa: People With Light Skin Are At Higher Risk of Skin Cancer. How to Reduce Sun Exposure
[The Conversation Africa] Most skin cancers are caused by too much exposure to the sun - specifically solar ultraviolet (UV) radiation or rays. These can damage the cells in the skin and cause them to mutate. This causes skin cancer. Melanoma is the most fatal kind of skin cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 1, 2023 Category: African Health Source Type: news
'Haircut could save your life': Red flag signs of cancer could appear on your scalp
There are two main types of skin cancer - non-melanoma and melanoma. (Source: Daily Express - Health)
Source: Daily Express - Health - January 26, 2023 Category: Consumer Health News Source Type: news
ICYMI: Cancer death rate continues to decline due to treatment advances
This report is the latest to document this progress. A growing body of evidence underscores the role of new medicines in recent accelerated declines in mortality across a range of cancers.One study found, between 2000 and 2016 alone, new cancer medicines were associated with nearly 1.3 million averted cancer deaths across the 15 most common tumor types. In particular, new cancer medicines were associated with nearly 130,000 prevented breast cancer deaths, nearly 400,000 prevented lung cancer deaths, and over 6500 melanoma deaths. While the ACS report highlights tremendous progress in the fight against cancer, it also ...
Source: The Catalyst - January 25, 2023 Category: Pharmaceuticals Authors: Matthew Norawong Tags: Medicines in Development Cancer Drug Cost Equity Source Type: news
‘This will happen before 2030’: how the science behind Covid vaccines might help to fight cancer
The success of mRNA-based drugs in combating coronavirus is inspiring scientists to create similar vaccines for melanoma and other tumoursIn December 2022, the US biotech firm Moderna, a company that emerged from relative obscurity to become a household name during the pandemic, published theresults of a clinical trialthat sent ripples through the world of cancer research.Conducted in partnership with the pharma company MSD, it demonstrated that a messenger RNA (mRNA) cancer vaccine, used in combination with immunotherapy, could offer significant benefit to patients with advanced melanoma who had received surgery to remove...
Source: Guardian Unlimited Science - January 22, 2023 Category: Science Authors: David Cox Tags: Cancer research Medical research Coronavirus Infectious diseases Science Source Type: news
